Jiangsu Vcare Pharmaceutical Technology Co., Ltd

This study tests a gel called VC005 on adults with mild to moderate atopic dermatitis (eczema). The goal is to see if it reduces skin redness, itching, and rash better than a gel with no active ingredient. About 120 participants will use the gel daily, and doctors will measure ch…

This early-stage study looks at how taking VC005 tablets with or without food changes the drug levels in the blood. It involves 30 healthy adults aged 18 to 45. The results will help decide the best way to take this medicine in future studies for atopic dermatitis (eczema).

This study looks at how a single 25 mg dose of VC005 tablets is processed by the body in people with kidney impairment compared to those with normal kidney function. The goal is to understand safety and drug levels in the blood. 32 adults will take part in this early-stage resear…

This early-stage study looks at how a single 25 mg dose of VC005 tablets is handled by the body in people with mild or moderate liver impairment compared to those with normal liver function. The goal is to measure drug levels and safety, not to treat the liver condition. 24 adult…